Anika Therapeutics Inc (ANIK)
28.04
+0.20
(+0.72%)
USD |
NASDAQ |
May 07, 11:19
Anika Therapeutics Cash from Investing (Quarterly): -1.84M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.84M |
| September 30, 2023 | -0.741M |
| June 30, 2023 | -1.457M |
| March 31, 2023 | -1.389M |
| December 31, 2022 | -2.529M |
| September 30, 2022 | -1.691M |
| June 30, 2022 | -1.94M |
| March 31, 2022 | -1.326M |
| December 31, 2021 | -1.24M |
| September 30, 2021 | -1.295M |
| June 30, 2021 | -2.317M |
| March 31, 2021 | 1.734M |
| December 31, 2020 | 16.81M |
| September 30, 2020 | 6.729M |
| June 30, 2020 | -2.299M |
| March 31, 2020 | -92.50M |
| December 31, 2019 | 41.02M |
| September 30, 2019 | 2.10M |
| June 30, 2019 | -1.516M |
| March 31, 2019 | -1.917M |
| December 31, 2018 | -2.581M |
| September 30, 2018 | -55.14M |
| June 30, 2018 | 7.26M |
| March 31, 2018 | 0.207M |
| December 31, 2017 | -0.724M |
| Date | Value |
|---|---|
| September 30, 2017 | -3.339M |
| June 30, 2017 | -7.992M |
| March 31, 2017 | -0.425M |
| December 31, 2016 | 0.345M |
| September 30, 2016 | -2.49M |
| June 30, 2016 | -2.951M |
| March 31, 2016 | -1.667M |
| December 31, 2015 | -12.94M |
| September 30, 2015 | -4.385M |
| June 30, 2015 | -6.896M |
| March 31, 2015 | -6.006M |
| December 31, 2014 | 12.62M |
| September 30, 2014 | -20.24M |
| June 30, 2014 | -0.4008M |
| March 31, 2014 | -0.2765M |
| December 31, 2013 | -0.5481M |
| September 30, 2013 | 0.1581M |
| June 30, 2013 | 0.0371M |
| March 31, 2013 | 0.0998M |
| December 31, 2012 | -0.2122M |
| September 30, 2012 | -0.147M |
| June 30, 2012 | -0.9214M |
| March 31, 2012 | -0.2241M |
| December 31, 2011 | -0.4464M |
| September 30, 2011 | -0.2982M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-92.50M
Minimum
Mar 2020
41.02M
Maximum
Dec 2019
-2.405M
Average
-1.389M
Median
Mar 2023
Cash from Investing (Quarterly) Benchmarks
| The Cooper Companies Inc | -324.10M |
| Staar Surgical Co | 22.40M |
| OrthoPediatrics Corp | 17.92M |
| NexGel Inc | -0.273M |
| Innovative Eyewear Inc | 2.010M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.638M |
| Cash from Financing (Quarterly) | 0.342M |
| Free Cash Flow | -7.215M |
| Free Cash Flow Per Share (Quarterly) | 0.1228 |
| Free Cash Flow to Equity (Quarterly) | 1.798M |
| Free Cash Flow to Firm (Quarterly) | 1.798M |
| Free Cash Flow Yield | -1.76% |